Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited

Biotechnology Research

North Melbourne, Victoria 43,529 followers

Developing theranostics (nuclear medicine) for prostate, kidney, glioblastoma, haematologic cancers and rare diseases.

About us

Telix is a biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic ('theranostic') radiopharmaceuticals. Telix is headquartered in Melbourne, Australia with commercial operations in the United States, Europe (Belgium and Switzerland) and Japan. Telix is developing a portfolio of radiopharmaceutical products that aims to address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX).

Industry
Biotechnology Research
Company size
501-1,000 employees
Headquarters
North Melbourne, Victoria
Type
Public Company
Founded
2015
Specialties
Oncology, Theranostics, Radiology, Radiopharmaceuticals, Cancer , Prostate Cancer, Renal Cancer, Glioblastoma, Positron Emission Tomography, Nuclear Medicine, Molecularly Targeted Radiation, Urology, Molecular Imaging, Cancer Imaging, and Cancer Therapy

Locations

Employees at Telix Pharmaceuticals Limited

Updates

Affiliated pages

Similar pages

Browse jobs